MOXIFLOXACIN Labatec gtt opht 5.45 mg 5 ml
7680664900026
CH-66490
S01AE07
11.07.1.
Active substances:
Reimbursement limitations:
DUPIXENT.01
Dermatite atopique - Adultes Pour le traitement des adultes, la seringue pré-remplie ou le stylo …
1 / 2
google
Details
- GTIN
- 7680664900026
- Pharmacode
- -
- Product number
- 6649001
- CPT
- -
- Packaging group
- 5
- Unit
- ml
- Composition
- moxifloxacinum 5 mg ut moxifloxacini hydrochloridum 5.45 mg acidum boricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 1 ml.
Articles (1)
Moxifloxacin Labatec, collyre en solution
Augentropfen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
moxifloxacinum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
moxifloxacini hydrochloridum
|
5.45 MG | Substance | WIZUS |
|
acidum boricum
|
- | Substance | HIMDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 66490
- Drug name
- Moxifloxacin Labatec, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01AE07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/10/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 11.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MOXIFLOXACIN Labatec gtt opht 5.45 mg 5 ml
- Description (DE)
- MOXIFLOXACIN Labatec Trp Opht 5.45 mg 5 ml
- Market launch
- 15/12/2025
- Narcotic (BTM)
- No